Posted: 29 May 2025 The Company: The client of our BioMelbourne Network member mexec, is a Melbourne-based, ASX-listed medical device company transforming nerve repair and improving patient outcomes. They have developed a unique approach to nerve replacement by…
Posted: 28 May 2025 The COVID-19 pandemic demonstrated the urgent need for better understanding of how viruses interact with our lungs. That’s the focus of the Doherty Institute’s Associate Professor Ash Haque and his team’s work: using a…
Posted: 28 May 2025 A groundbreaking partnership between the Victorian Heart Institute at Monash University and NewAmsterdam Pharma has been recognised on the global stage, winning Clinical Partnership of the Year – Non-CRO at the 2025 Citeline Awards…
Posted 28 May 2025 CSL Behring’s new facility in Broadmeadows, Victoria, has been named the 2025 Facility of the Year by the International Society for Pharmaceutical Engineering (ISPE), in the Pharma 4.0 category. The site has recently started…
Posted: 26 May 2025 Brandon Capital has opened the second funding round for its Cureator Dementia and Cognitive Decline incubator program with up to $5 million for each project. The CUREator+ Dementia and Cognitive Decline incubator program is…
This article outlines the official launch of the Australian Medtech Manufacturing Alliance (AMMA)’s strategic plan, and captures the key themes of the inaugural AMMA virtual forum – procurement barriers, policy alignment, workforce capability, and sector collaboration – while…
More than 600 people filled the Grand Ballroom of the Sofitel Melbourne on Collins for BioMelbourne Network’s highly anticipated 2025 Connecting Women Lunch – a flagship celebration of women and people identifying as women across our health technology…
Posted: 13th May 2025 Monash University received $953,751 from the Federal Government’s Medical Research Future Fund to study human brain cells for potential dementia treatments. This grant enabled the Monash Institute of Pharmaceutical Sciences to “light up” human…
Posted: 13th May 2025 A significant advancement in vaccine technology has been made by WEHI scientists, potentially leading to long-lasting vaccines against viruses and enhanced cancer therapies. The study, published in the Journal of Experimental Medicine, utilized a…
Posted: 9 May 2025 MEDIA RELEASE Buy Local Push with ‘Pathway to Market’ Program Opening for Homegrown Medtech Makers With a focus on local procurement, MTPConnect has launched its Pathway to Market – Medtech Capability Uplift Program…
Posted: 6th May 2025 4D Medical announced a significant agreement with Intermountain Health, a leading healthcare network based in Salt Lake City, Utah. The agreement saw 4D Medical’s advanced pulmonary hypertension analysis algorithm, powered by artificial intelligence (AI),…
Posted: 2nd May 2025 VivaZome Therapeutics Pty Ltd (“VivaZome”) have unveiled promising results at an international conference from their latest research on Traumatic Brain Injury (TBI) treatment. The findings, presented by Chief Scientific Officer Professor David Haylock at…